Balanced news tone
News Sentiment
PIII sentiment intelligence
P3 Health Partners Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
74/100 classification confidence.
directly relevant articles
high-authority source matches
-13.8% over one week, -19.9% over four weeks, trend active, and below fair value.
P3 Health Partners Company Profile & Introduction
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
P3 Health Partners Company Profile & Introduction
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 14:49
- Source
- Moomoo
P3 Health Partners(PIII) Stock Options Chain | Quotes & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 14:30
- Source
- Moomoo
PIII stock reflects P3 Health Partners growth efforts in US value-based care
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jul 2026 13:27
- Source
- Ad Hoc News
P3 Health Partners (PIII) extends promissory note to 2028 with 14% PIK interest
P3 Health Partners Inc. (PIII) has extended a promissory note through its subsidiary P3 Health Group, LLC with IHC Health Services, Inc., pushing the maturity date to September 30, 2028. The amendment introduces a 14% payment-in-kind (PIK) interest rate starting June 30, 2026, me
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 20:40
- Source
- Stock Titan
P3 Health Partners (PIII) Stock Sees Fair Value Lift After Strong EBITDA And Guidance
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 27 Jun 2026 07:00
- Source
- Market source
Enterprise value to EBIT forward of P3 Health Partners Inc. – NASDAQ:PIII
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 19:19
- Source
- TradingView
P3 Health Partners Inc. Class A Actuals & Estimates (NASDAQ:PIII)
This article provides an overview of P3 Health Partners Inc. (NASDAQ: PIII) stock performance, financial actuals and estimates, and various analyses. It details the current stock price, recent fluctuations, analyst forecasts, historical highs and lows, market capitalization, and
- Tone
- Positive 60/100
- Event
- Analyst action
- Published
- 26 Jun 2026 14:10
- Source
- TradingView
P3 Health Partners Inc. Class A Actuals & Estimates (BOATS:PIII)
This article provides financial actuals and estimates for P3 Health Partners Inc. (PIII) on the Blue Ocean Alternative Trade System (BOATS). It includes information on the company's stock ticker, analyst price forecasts, historical high and low prices, earnings reports, revenue,
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 02:10
- Source
- TradingView
P3 Health Partners (PIII) holder converts 50K P3 LLC Units to Class A
Hudson Vegas Investment SPV, LLC, a large shareholder in P3 Health Partners (PIII), converted 50,000 P3 LLC Units into 50,000 shares of Class A Common Stock. Concurrently, 50,000 shares of Class V Common Stock were forfeited for no consideration. This transaction follows a 1-for-
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 21:39
- Source
- Stock Titan
[8-K] P3 Health Partners Inc. Reports Material Event
P3 Health Partners Inc. filed an 8-K report detailing the results of its 2026 Annual Meeting of Stockholders held on June 9, 2026. Stockholders voted on four key proposals, including the election of three Class II directors, the ratification of BDO USA, P.C. as the independent ac
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Jun 2026 10:38
- Source
- Stock Titan
P3 Health Partners (PIII) Pullback: Is $12.38 a Re-Entry Buy Opportunity?
P3 Health Partners (PIII) recently pulled back to $12.38 from an $18.52 post-earnings high, following significant profit-taking. Despite the drop, the company's fundamentals remain strong, with a Q1 profit of $3M compared to a $44.2M loss a year ago, $26M EBITDA, and a strengthen
- Tone
- Positive 73/100
- Event
- Earnings
- Published
- 30 May 2026 12:09
- Source
- TradingKey
P3 Health Partners (PIII) Stock Jumps 488% in 30 Days — 2026 Revenue Boom and Debt Cut Fuel Rally
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 29 May 2026 07:00
- Source
- FXLeaders
P3 Health Partners (NASDAQ: PIII) back in full Nasdaq listing compliance
P3 Health Partners Inc. announced it has regained compliance with Nasdaq's continued listing standards, specifically Listing Rule 5550(b)(2) concerning the market value of listed securities. This decision by Nasdaq staff, made on May 20, 2026, was based on the company's SEC filin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 19:39
- Source
- Stock Titan
SGRY - Surgery Partners Inc Stock Price and Quote
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 14:30
- Source
- Finviz
P3 Health Partners Inc. Class A Common Stock (PIII) Stock Price Today & Analysis
This article provides an analysis of P3 Health Partners Inc. Class A Common Stock (PIII), including its current stock price, fundamental financials, and corporate information. It also details how to buy PIII stock through the Gotrade app, explains the minimum investment, and clar
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 11:09
- Source
- Gotrade
Earnings call transcript: P3 Health Partners sees strong Q1 2026 turnaround
P3 Health Partners (PIII) reported a significant financial turnaround in Q1 2026, achieving an adjusted EBITDA of $26 million, a $48 million improvement year-over-year. This positive performance is attributed to strategic restructuring, cost management, and improved payer contrac
- Tone
- Positive 74/100
- Event
- Earnings
- Published
- 20 May 2026 16:39
- Source
- Investing.com Canada
P3 Health Partners Swung to Profit and Beat EPS by $5.17 — Is PIII Stock a Buy at $10?
P3 Health Partners (PIII) reported a significant Q1 2026 earnings surprise, with an EPS of $0.32 against an estimated -$4.85, and a substantial increase in medical margin per member per month. The company also raised its full-year 2026 adjusted EBITDA guidance and completed a deb
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 20 May 2026 12:30
- Source
- TradingKey
What's Going On With P3 Health Partners Stock Monday?
P3 Health Partners (NASDAQ: PIII) stock experienced a decline on Monday, following a significant 180% surge on Friday due to profit-taking by retail traders. The previous rally was driven by the company beating analyst earnings estimates, despite missing revenue forecasts. An ana
- Tone
- Negative 41/100
- Event
- Earnings
- Published
- 19 May 2026 22:11
- Source
- Sahm
P3 Health Partners (PIII) CFO awarded 30,000 stock options at $3.5479
P3 Health Partners (PIII) CFO Leif Elliott Pedersen was granted 30,000 stock options with an exercise price of $3.5479 per share. These options become exercisable on May 8, 2030, and expire on May 8, 2036. Following this grant, Pedersen now holds a total of 45,000 stock options,
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 21:39
- Source
- Stock Titan
P3 Health Partners (PIII) Stock Surges Over 42% After Hours: Here's Why
P3 Health Partners (PIII) shares surged over 42% after-hours following strong first-quarter 2026 results, which saw the company beat analyst EPS estimates and report a significant turnaround from a year-ago loss. The Nevada-based health management company's revenue increased and
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 17 May 2026 09:10
- Source
- Sahm
P3 Health Partners completes debt exchange and equity raise, says Nasdaq compliance regained
P3 Health Partners Inc. has completed a debt exchange and equity raise to regain compliance with Nasdaq's minimum stockholders' equity requirements. The company exchanged $252.5 million in debt for preferred stock and sold $30 million of a planned $70 million in new units to affi
- Tone
- Positive 67/100
- Event
- Balance sheet
- Published
- 16 May 2026 22:11
- Source
- Investing.com UK
P3 Health Partners Soars After Dramatic Q1 Turnaround
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 May 2026 07:00
- Source
- timothysykes.com
P3 Health Partners (NASDAQ: PIII) cuts debt, adds 19.5% preferred to meet Nasdaq equity rule
P3 Health Partners (NASDAQ: PIII) has restructured its balance sheet to comply with Nasdaq's minimum stockholders' equity requirement. The company exchanged approximately $252.5 million in promissory notes for non-convertible preferred stock and secured $30 million from a $70 mil
- Tone
- Positive 64/100
- Event
- Balance sheet
- Published
- 15 May 2026 21:12
- Source
- Stock Titan
P3 Health Partners turns profit in Q1, lifts 2026 forecast
P3 Health Partners Inc. reported a first-quarter profit of $3.0 million, a turnaround from a $44.2 million loss a year ago, and saw its shares surge. The company also raised its 2026 adjusted EBITDA target to between $20 million and $60 million. Despite this positive financial pe
- Tone
- Positive 74/100
- Event
- Earnings
- Published
- 15 May 2026 20:39
- Source
- TechStock²
P3 Health Partners surges 228% after Q1 turnaround and higher 2026 EBITDA outlook
P3 Health Partners (PIII) shares surged 228.3% after reporting a strong Q1 2026 turnaround, including positive adjusted EBITDA and a swing to net income. The company also raised its full-year 2026 adjusted EBITDA guidance to $20 million–$60 million, with revenues of $386 million,
- Tone
- Positive 95/100
- Event
- Guidance
- Published
- 15 May 2026 15:50
- Source
- Quiver Quantitative
P3 Health Partners Inc. Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- Market source
P3 Health Partners Inc (PIII) Q1 2026 Earnings Call Highlights: Surpassing Expectations and ...
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 May 2026 05:02
- Source
- GuruFocus.com
P3 Health Partners Q1 2026 Earnings Call Transcript
P3 Health Partners reported strong Q1 2026 results with $26 million in adjusted EBITDA, significantly exceeding internal expectations, and raised its full-year 2026 outlook. The company attributes this performance to improved payer contract structures, disciplined operational exe
- Tone
- Positive 72/100
- Event
- Earnings
- Published
- 15 May 2026 02:09
- Source
- MarketBeat
P3 Health Partners Q1 Swings to Earnings, Revenue Rises
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 21:31
- Source
- MT Newswires
P3 Health Partners Announces First Quarter 2026 Results
P3 Health Partners Inc. announced its First Quarter 2026 results. The announcement was made via a press release distributed by Quantisnow, a platform that provides real-time market data and news to retail investors. Quantisnow Plus members were alerted to this news shortly after
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 21:40
- Source
- Quantisnow